Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Eligible age
Up to 21 yrs
Accepts
All genders
Locations
34 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Continuation of the CARRA Registry as described in the protocol will support data collection on patients with pediatric-onset rheumatic diseases. The CARRA Registry will form the basis for future CARRA studies. In particular, this observational registry will be used to answer pressing questions about therapeutics used to treat pediatric rheumatic diseases, including safety questions.
Sponsor: Duke University
You may qualify if…
- ✓ 1. Onset of rheumatic disease prior to age 16 years for JIA and onset prior to age 19 years for all other rheumatic diseases (see appendix A).
- ✓ 2. Subject (and/or parent/legal guardian when required) is able to provide written informed consent and willing to comply with study procedures.
- ✓ 3. Subject and/or parent/legal guardian is willing to be contacted in the future by study staff.
You may not qualify if…
- ✕ 1\. Greater than 21 years of age at the time of enrollment.
Where it's recruiting
Birmingham
Phoenix
Los Angeles · Palo Alto · San Diego · San Francisco
Aurora
Hartford · New Haven
Washington D.C.
Gainesville · Miami · Orlando · St. Petersburg
Atlanta · Augusta
Chicago
Indianapolis
Iowa City
Kansas City
Source: ClinicalTrials.gov · NCT02418442 · last updated 2025-10-14